Eric K. Rowinsky
2012
In 2012, Eric K. Rowinsky earned a total compensation of $1.2M as Executive Vice President, Chief Medical Officer and Head of Research and Development at Stemline Therapeutics, a 2,704% increase compared to previous year.
Compensation breakdown
| Option Awards | $918,515 |
|---|---|
| Salary | $250,000 |
| Total | $1,168,515 |
Rowinsky received $918.5K in option awards, accounting for 79% of the total pay in 2012.
Rowinsky also received $250K in salary.
Rankings
In 2012, Eric K. Rowinsky's compensation ranked 5,525th out of 11,487 executives tracked by ExecPay. In other words, Rowinsky earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,525 out of 11,487 | 52nd |
Division Manufacturing | 1,950 out of 4,253 | 54th |
Major group Chemicals And Allied Products | 473 out of 1,198 | 61st |
Industry group Drugs | 315 out of 920 | 66th |
Industry Pharmaceutical Preparations | 246 out of 700 | 65th |
Source: SEC filing on April 30, 2015.
Rowinsky's colleagues
We found four more compensation records of executives who worked with Eric K. Rowinsky at Stemline Therapeutics in 2012.